Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Dec, 15 2025
Jan, 2 2026
Dec, 30 2025
Dec, 1 2025
Jul, 27 2025